announced the appointment of Jason D. Sawyer to its board of directors, effective immediately, to fill a vacancy, according to a press release statement filed with the Securities and Exchange Commission. The decision was made by the company’s board on Friday.
Mr. Sawyer will serve as a director until Greenland Mines’ next annual meeting of stockholders and until a successor is duly elected and qualified, or until his earlier resignation or removal. At this time, Mr. Sawyer has not been named to any board committees.
The filing states that Mr. Sawyer has no family relationships with any of the company’s executive officers or directors and is not involved in any related party transactions that require disclosure under Item 404(a) of Regulation S-K. He has not entered into any agreement with Greenland Mines in connection with his appointment as a director.
According to the company’s disclosure, Mr. Sawyer, age 54, is a 33-year veteran of the alternative investment industry and currently serves as General Manager of Access Alternative Group S.A., a venture investment and advisory firm based in Nassau, Bahamas. Over his career, he and his affiliated firms have raised more than $5 billion in alternative assets and invested over $300 million in early and growth-stage companies across various sectors.
Mr. Sawyer’s previous roles include Principal at Crane Capital Associates, Head of its Absolute Return Strategies Group, and Founding Partner of Candlebrook Capital. He has also co-founded and financed several ventures in software, health, and consumer products.
Mr. Sawyer currently serves as CEO and director of GridAI Technologies Corp. (NASDAQ:GRDX), Head of Finance and M&A at Quantum BioPharma (NASDAQ:QNTM), director of The FUTR Corp. (TSX.V:FTRC), director of Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT), and director of Perpetuals.com (NASDAQ:PDC).
Greenland Mines Ltd’s common stock and warrants trade on the Nasdaq Stock Market under the symbols GRML and GRMLW, respectively. The company is classified under biological products (excluding diagnostic substances).
All information is based on a press release statement filed with the SEC.
In other recent news, Greenland Mines Ltd received a 180-day extension from to meet the minimum bid price requirement, which mandates a closing bid price of at least $1.00 per share for 10 consecutive business days. This extension is crucial for maintaining its Nasdaq listing. Previously known as Klotho Neurosciences, the company rebranded to Greenland Mines Ltd, along with a change in its stock ticker to GRML. This rebranding coincides with the acquisition of Greenland Mines Corp., granting an 80% interest in the Skaergaard Project, a significant – project in Southeast Greenland. The project boasts a resource estimate of 364.37 million tons at 2.17 g/t palladium equivalent, including substantial amounts of palladium, gold, and other minerals. Additionally, Greenland Mines completed a private placement, raising approximately $7.75 million through the issuance of shares and warrants. These developments reflect the company’s strategic efforts to enhance its resource portfolio and financial standing.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Read the full article here
